id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-V-6101-0006,FDA,FDA-2019-V-6101,Variance Approval to Donovan Rosling Rosling from FDA CDRH,Other,Approval for Variance (VRA),2021-08-30T04:00:00Z,2021,8,2021-08-30T04:00:00Z,,2021-08-30T16:36:08Z,,0,0,0900006484cb2c39
FDA-2019-V-6101-0004,FDA,FDA-2019-V-6101,Variance Renewal Request from Donovan Rosling,Other,Request,2021-07-16T04:00:00Z,2021,7,2021-07-16T04:00:00Z,,2021-07-16T20:05:57Z,,0,0,0900006484bfe6ab
FDA-2019-V-6101-0005,FDA,FDA-2019-V-6101,CDRH Variance Package Cover Sheet re Variance Renewal Request from Donovan Rosling,Supporting & Related Material,Background Material,2021-07-16T04:00:00Z,2021,7,,,2021-07-16T20:07:40Z,,0,0,0900006484bfe6ad
FDA-2019-V-6101-0003,FDA,FDA-2019-V-6101,Letter from FDA CDRH to Donovan Rosling,Other,Letter(s),2020-02-06T05:00:00Z,2020,2,2020-02-06T05:00:00Z,,2020-02-06T15:30:49Z,,0,0,0900006484334a2e
FDA-2019-V-6101-0001,FDA,FDA-2019-V-6101,Variance Application from Donovan Rosling Rosling,Other,Application for Variance (VAR),2019-12-31T05:00:00Z,2019,12,2019-12-31T05:00:00Z,,2019-12-31T19:37:37Z,,0,0,090000648425ea93
FDA-2019-V-6101-0002,FDA,FDA-2019-V-6101,Acknowledgment Letter from FDA DMS to Donovan Rosling Rosling,Other,Acknowledgement Letter/Receipt,2019-12-31T05:00:00Z,2019,12,2019-12-31T05:00:00Z,,2019-12-31T19:40:18Z,,0,0,090000648425eaab